Corporate Communications Director, BioPharmaceuticals
Locations: Cambridge UK, Gaithersburg US
Summary:
The Director of Corporate Communications, BioPharmaceuticals leads corporate and internal communications for the BioPharmaceuticals organisation (BioPharma), enhancing understanding of BioPharma's business and building a positive reputation for its therapy areas, science and leadership. The role also serves as the functional lead for internal communications for BioPharma and as the lead communications support to the EVP, Biopharmaceuticals Business Unit (BBU) within the BioPharma organisation, covering external and internal communications for the BBU.
AstraZeneca BioPharmaceuticals encompasses the BioPharmaceuticals R&D organisation and three therapy areas: Cardiovascular, Renal and Metabolism (CVRM), Respiratory & Immunology (R&I) and the Vaccines & Immune Therapies Unit (V&I). We focus on delivering life-changing medicines for people living with the most common chronic diseases and providing immunity against pathogens where there is significant unmet need.
The successful candidate will have expert corporate communications and excel in developing powerful narratives for the biopharma sector through multi-faceted communications/campaigns that include media interactions, investors relations, external and internal digital/social channels and external/internal presentations.
The role is a member of the BioPharma Global Corporate Affairs Leadership Team, reporting to the VP Global Corporate Affairs BioPharma. The role manages a small team which has a focus on delivery corporate and internal communications for BioPharma. The role collaborates closely across with colleagues across BioPharma GCA and GCA more broadly, particularly the Heads of R&D BioPharma GCA and the Heads of the three corporate affairs therapy areas. More broadly the role collaborates closely with BBU LT members and other functions throughout the organisation.
Key responsibilities:
Subscribe to job alerts and upload your resume!
*By registering with our site, you agree to our
Terms and Privacy Policy.